Inside the Viral Tanning Peptide That Accidentally Created Vyleesi’s FDA-Approved Low Sex Drive Drug

Unverified "sunless tanning" injections are exploding across social media, but their real scientific legacy isn't a dark ...
WebMD

Navigating HSDD With Vyleesi: What You Need to Know

You may have heard about Vyleesi (bremelanotide), a medicine approved by the FDA to treat low sex drive, called hypoactive sexual desire disorder (HSDD), in premenopausal women. HSDD is the most ...
Nasdaq

Palatin Announces Direct-to-Consumer Telehealth Partnership with UpScriptHealth™ for Vyleesi®

Partnership will increase hypoactive sexual desire disorder (HSDD) awareness and expand access to Vyleesi via UpScriptHealth's Women's Health Platform "We are excited to partner with UpScriptHealth, a ...
Fox 5 San Diego

Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension

CRANBURY, N.J., Feb. 28, 2023 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ...